The FDA has given AliveCor 510(k) clearance to market an algorithm that can accurately identify the presence of atrial fibrillation using the company's smartphone-based ECG. The technology allows patients to take ECG readings using their Android or Apple mobile devices, and send the information to a cardiologist to confirm whether they have atrial fibrillation.

Full Story:

Related Summaries